EORTC Recurrence Score Analysis from the Pivotal ENVISION Trial to be Presented at the 2026 American Society of Clinical Oncology’s ...
Phase III Randomized, Placebo-Controlled Trial of Endocrine Therapy ± 1 Year of Everolimus in Patients With High-Risk, Hormone Receptor–Positive, Early-Stage Breast Cancer Multicenter prospective ...
MedPage Today on MSN
Paradigm shift for evaluating, treating biochemical recurrence in prostate cancer
When PSA rises after surgery, PSMA PET/CT detects cancer missed by conventional imaging ...
Postdiagnosis exercise is associated with lower breast cancer (BC) mortality but its link with risk of recurrence is less clear. We investigated the impact and dose-response relationship of exercise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results